New study reports: “No benefit of Celecoxib in Breast Cancer Patients”A recent study looking at the use of the non-steroidal anti-inflammatory drug (NSAID), celecoxib, in participants who have had sur ...
All Cancer News
Further evidence of the benefits of taking aspirin for people with bowel cancer
A recent report has provided further evidence to suggest that individuals who take aspirin following a diagnosis of colorectal (bowel) cancer are less likely to die from their cancer. The study included 2400 individuals with bowel cancer from Australia, Canada and the U.S...
Further research suggests aspirin can reduce risk of breast cancer
A new piece of research has provided further evidence to suggest that individuals who take aspirin have a lower risk of developing breast cancer. Researchers collected information from 57,000 female teachers in California over a period of more than 15 years. ...
Further research suggests aspirin may reduce risk of dying from cancer
Further research has provided more evidence to suggest that individuals who take aspirin have a lower risk of dying from cancer. Researchers looked at data from two very large studies that followed groups of nurses and other healthcare professionals (more than 130,000 people in total) over a period of up to 32 years...
Add-Aspirin receives donation from Friends of Cancer Research UK
Lead researcher Professor Ruth Langley was delighted to accept a donation of £45,000 on behalf of CRUK from the Putney, Barnes, Sheen and Kew Group of Friends of Cancer Research UK. This donation was a result of the South West London Christmas Fair fundraising event organised by the group in November 2016.
News and Resources